Dexcom (DXCM) Other Non-Current Assets (2010 - 2026)
Dexcom (DXCM) posted quarterly Other Non-Current Assets of $273.7 million for Q2 2026, up 55.95% year-over-year from $175.5 million in Q2 2025, and down 4.27% quarter-over-quarter from $285.9 million in Q1 2026.
Dexcom (DXCM) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Other Non-Current Assets for 17 consecutive years, with $273.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non-Current Assets rose 55.95% year-over-year to $273.7 million; the TTM figure through Jun 2026 stood at $273.7 million (up 55.95% YoY), while the FY2025 annual figure was $278.7 million, up 61.1% from the prior year.
- Other Non-Current Assets slipped to $273.7 million in Q2 2026 per DXCM's latest filing, from $285.9 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $285.9 million in Q1 2026 and bottomed at $22.8 million in Q1 2022.
- Historically, Other Non-Current Assets has averaged $126.8 million across 5 years, with a median of $80.3 million in 2024.
- On a YoY basis, Other Non-Current Assets climbed as much as 348.57% in 2022 and fell as far as 6.44% in 2022.
- Dexcom's Other Non-Current Assets stood at $47.1 million in 2022, then jumped by 59.24% to $75.0 million in 2023, then soared by 130.67% to $173.0 million in 2024, then surged by 61.1% to $278.7 million in 2025, then fell by 1.79% to $273.7 million in 2026.
- Business Quant data shows DXCM's Other Non-Current Assets at $273.7 million in Q2 2026, $285.9 million in Q1 2026, and $278.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 3.23 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 4.15 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 616.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 273.70 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 148.78 Mn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 215.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 273.70 Mn |
| Mar 31, 2026 | 285.90 Mn |
| Dec 31, 2025 | 278.70 Mn |
| Sep 30, 2025 | 276.50 Mn |
| Jun 30, 2025 | 175.50 Mn |
| Mar 31, 2025 | 168.50 Mn |
| Dec 31, 2024 | 173.00 Mn |
| Sep 30, 2024 | 88.20 Mn |
| Jun 30, 2024 | 82.90 Mn |
| Mar 31, 2024 | 77.70 Mn |
| Dec 31, 2023 | 75.00 Mn |
| Sep 30, 2023 | 74.40 Mn |
| Jun 30, 2023 | 66.90 Mn |
| Mar 31, 2023 | 56.60 Mn |
| Dec 31, 2022 | 47.10 Mn |
| Sep 30, 2022 | 33.70 Mn |
| Jun 30, 2022 | 24.80 Mn |
| Mar 31, 2022 | 22.80 Mn |
| Dec 31, 2021 | 10.50 Mn |
| Jun 30, 2021 | 23.30 Mn |